Futern AI
Product
Solution
Pricing
Log in
Start for Free
AX
Adrian Xu
CEO
at
益方生物 Inventisbio
View Adrian's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.
Get Started for Free
Work Experience
益方生物 Inventisbio
CEO
2021 - Present · 3 years and 11 months
Merck
In Vivo Pharmacology Capability Lead - Oncology
2010 - 2021 · 11 years
Baylor College of Medicine
Postdoctoral Fellow With Dr. Bert O'Malley
2009 - 2010 · 1 years
Explore Full Profile for Free
Company Details
益方生物 Inventisbio
11-50 Employees
益方生物科技(上海)有限公司是一家成立于2013年的创业型生物医药公司,致力于肿瘤,肿瘤免疫,代谢领域的新药研发,公司产品管线已包含肺癌、乳腺癌,肿瘤免疫和痛风等领域靶向治疗的小分子候选药物,同时公司也在积极开发其他肿瘤及免疫肿瘤靶点的药物。公司目前有四个自主研发的1类新药,分别在中、美两地进行临床一、二期试验。 益方的目标不仅是要让中国而且是要让全世界的患者从我们研发的新药中受益,与此同时,我们也在资本市场上获得认可(2017年获得奥博资本与礼来亚洲基金的投资),与他们的战略合作将为公司今后的方向打下坚实的基础,在未来的全球医药市场上获得快速发展。
Website
http://www.inventisbio.com
Year Founded
2013
Social Media
Linkedin
Industry
Pharmaceutical Manufacturing, Scientific Research and Development Services, Services
HQ Location
上海市浦东新区张衡路1000弄63号 上海市, 上海市 201203, CN
Keywords
生物医药
临床项目
and 新药研发
clinical recruitment
breakthrough therapy identification
therapy identification
Discover More About Cleveland Clinic
Contact Details
Email Address
A**@inventisbio.com
Reveal Email
Phone Number
(xxx)xxx-xxxx
Reveal Phone
You May Also Interested In
AV
Anco Van Dijk
Operator Awzi ,Operator Suspensie`S
Worked together at Merck
Details
SG
Shannon Greenfield
Worked together at Merck
Details
LS
Lawrence Senour
Worked together at Merck
Details
Find More Connections
Find verified contacts of Adrian Xu in seconds from 700M people profiles. Start now!
Start for Free
Continue with Google
No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.